Laddar...
A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.
Twelve premenopausal patients with advanced breast cancer were randomised to receive 3.75 or 7.5 mg of a slow release formulation of the luteinising hormone releasing hormone agonist leuprorelin once every 4 weeks. All patients were oestrogen receptor positive or unknown. Serum levels of gonadotroph...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
1990
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1971512/ https://ncbi.nlm.nih.gov/pubmed/2123115 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|